(Q48420288)

11 February 2018

title

Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6-hydroxydopamine (English)

1 reference

11 February 2018

Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6‐Hydroxydopamine (English)

1 reference

https://api.crossref.org/works/10.1002/MDS.870130409

2 January 2025

1 reference

1 reference

1 reference

M. Gassen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9686771

2 January 2025

A. Gross

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9686771

2 January 2025

M. B. Youdim

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9686771

2 January 2025

language of work or name

English

0 references

publication date

1 July 1998

1 reference

11 February 2018

July 1998

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9686771

full work available at URL

2 January 2025

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmds.870130409

1 reference

https://api.crossref.org/works/10.1002/MDS.870130409

https://onlinelibrary.wiley.com/doi/full/10.1002/mds.870130409

2 January 2025

1 reference

https://api.crossref.org/works/10.1002/MDS.870130409

2 January 2025

1 reference

11 February 2018

volume

13

1 reference

11 February 2018

issue

4

1 reference

11 February 2018

page(s)

661-667

1 reference

11 February 2018

The inherent cytotoxicity of melanin precursors: a revision

cites work

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870130409

The iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1002/MDS.870130409

Reactive oxygen species and the central nervous system

2 January 2025

2

1 reference

https://api.crossref.org/works/10.1002/MDS.870130409

Oxidative stress: free radical production in neural degeneration.

2 January 2025

3

1 reference

https://api.crossref.org/works/10.1002/MDS.870130409

Iron in brain function and dysfunction with emphasis on Parkinson's disease

2 January 2025

4

1 reference

https://api.crossref.org/works/10.1002/MDS.870130409

Altered brain metabolism of iron as a cause of neurodegenerative diseases?

2 January 2025

5

1 reference

https://api.crossref.org/works/10.1002/MDS.870130409

Catechol adrenergic agents enhance hydroxyl radical generation in xanthine oxidase systems containing ferritin: implications for ischemia/reperfusion

2 January 2025

6

1 reference

https://api.crossref.org/works/10.1002/MDS.870130409

Iron-melanin interaction and lipid peroxidation: implications for Parkinson's disease

2 January 2025

8

1 reference

https://api.crossref.org/works/10.1002/MDS.870130409

Dopamine agonists in Parkinson's disease: a look at apomorphine

2 January 2025

9

1 reference

https://api.crossref.org/works/10.1002/MDS.870130409

Apomorphine is a highly potent free radical scavenger in rat brain mitochondrial fraction

2 January 2025

10

1 reference

https://api.crossref.org/works/10.1002/MDS.870130409

PC12 pheochromocytoma cells: culture, nerve growth factor treatment, and experimental exploitation

2 January 2025

11

1 reference

https://api.crossref.org/works/10.1002/MDS.870130409

Effects of extracellular ATP on Fe(2+)-induced cytotoxicity in PC-12 cells

2 January 2025

12

1 reference

https://api.crossref.org/works/10.1002/MDS.870130409

Cytotoxic effects of an oxidative stress on neuronal-like pheochromocytoma cells (PC12).

2 January 2025

13

1 reference

https://api.crossref.org/works/10.1002/MDS.870130409

Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. Implications for the treatment of Parkinson's disease

2 January 2025

14

1 reference

https://api.crossref.org/works/10.1002/MDS.870130409

Cytotoxic effects of glutamic acid on PC12 cells☆

2 January 2025

15

1 reference

https://api.crossref.org/works/10.1002/MDS.870130409

Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: relevance to Parkinson's disease

2 January 2025

16

1 reference

https://api.crossref.org/works/10.1002/MDS.870130409

Peroxynitrite-induced cytotoxicity in PC12 cells: evidence for an apoptotic mechanism differentially modulated by neurotrophic factors

2 January 2025

17

1 reference

https://api.crossref.org/works/10.1002/MDS.870130409

Prevention of dopamine-induced cell death by thiol antioxidants: possible implications for treatment of Parkinson's disease.

2 January 2025

18

1 reference

https://api.crossref.org/works/10.1002/MDS.870130409

Free radical scavenging properties of apomorphine enantiomers and dopamine: Possible implication in their mechanism of action in parkinsonism

2 January 2025

19

1 reference

https://api.crossref.org/works/10.1002/MDS.870130409

The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls

2 January 2025

21

1 reference

https://api.crossref.org/works/10.1002/MDS.870130409

Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson's Disease Research Group

2 January 2025

22

1 reference

https://api.crossref.org/works/10.1002/MDS.870130409

Neurotoxicity of levodopa on catecholamine-rich neurons

2 January 2025

23

1 reference

https://api.crossref.org/works/10.1002/MDS.870130409

The Therapeutic Potential of Moclobemide, a Reversible Selective Monoamine Oxidase A Inhibitor in Parkinson's Disease

2 January 2025

24

1 reference

https://api.crossref.org/works/10.1002/MDS.870130409

Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa. Parkinson Study Group

2 January 2025

25

1 reference

https://api.crossref.org/works/10.1002/MDS.870130409

A study on the effect and tolerance of lisuride on Parkinson's disease

2 January 2025

26

1 reference

https://api.crossref.org/works/10.1002/MDS.870130409

Motor response to acute dopaminergic challenge with apomorphine and levodopa in Parkinson's disease: implications for the pathogenesis of the on-off phenomenon

2 January 2025

27

1 reference

https://api.crossref.org/works/10.1002/MDS.870130409

2 January 2025

Identifiers

1 reference

11 February 2018

1 reference

11 February 2018